Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Epidemiology, Diagnosis, and Therapy of Fungal Infections in Surgery
1996
Risk Factors for Death in Patients With Candidemia
1998
Antimicrobial therapy for patients with severe sepsis and septic shock: An evidence-based review
2004
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
2002
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Vulvovaginal candidosis
2007 Standout
The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients
2008
Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
2000
Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
2001
Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for Death
2002
A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients
2003
Practice Guidelines for the Treatment of Candidiasis
2000
Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
2009
Candidal Brain Abscess Associated with Vascular Invasion: A Devastating Complication of Vascular Catheter-Related Candidemia
1995
Effects of nosocomial candidemia on outcomes of critically ill patients
2002
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Candidemia in a Tertiary Care Cancer Center
2003
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
2003
A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia
1994
Investigation of the possible association between nosocomial candiduria and candidaemia
2006
Systemic candidiasis in intensive care units: A multicenter, matched-cohort study
2002
Invasive Candida species infections: a 5 year population-based assessment
2005
Risk Factors for Death Among Cancer Patients with Fungemia
1998
Purulent Pericarditis Caused by Candida Species: Case Report and Review
1995
Candidemia in a Tertiary Care Hospital: Epidemiology and Factors Influencing Mortality
2003
Antifungal Agents. Part II. The Azoles
1999
DERMATOLOGIC INFECTIONS IN THE IMMUNOCOMPROMISED (Non-HIV) HOST
2001
Intravascular Catheter Exchange and Duration of Candidemia
1995
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
1997
Candidemia in French hospitals: incidence rates and characteristics
2002
Polymerase Chain Reaction for the Diagnosis of Candidemia
1993
Guillain–Barré Syndrome
2012 Standout
Should Vascular Catheters Be Removed from All Patients with Candidemia? An Evidence-Based Review
2002
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection
2004
Risk Factors and Outcomes of Fungal Ventricular‐Assist Device Infections
2010
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Severe Sepsis and Septic Shock
2013 Standout
Candidal Vertebral Osteomyelitis: Report of 6 Patients, and a Review
2001
Guideline for Prevention of Surgical Site Infection, 1999
1999 Standout
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
1996
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
1998
Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials
2009
The changing epidemiology of invasive candidiasis
2008
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care
1998
Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature
2012
Use of Amphotericin B During Pregnancy: Case Report and Review
1994
Nosocomial Candidemia in Non-Neutropenic Patients at an Italian Tertiary Care Hospital
2000
Neutrophil extracellular traps in immunity and disease
2017 Standout
A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
2009
Has the Epidemiology of Nosocomial Candidemia Changed?
2004
Echinocandin antifungal drugs
2003 Standout
Caspofungin for the treatment of less common forms of invasive candidiasis
2007
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis
1999
Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy
2003
Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients
2005 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
1999 Standout
The Future of Antifungal Therapy
1996
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
2002 Standout
Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study
2001
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study
2006 Standout
Management of Invasive Candidal Infections: Results of a Prospective, Randomized, Multicenter Study of Fluconazole Versus Amphotericin B and Review of the Literature
1996
Risk Factors forCandida tropicalisFungemia in Patients with Cancer
2001
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials
2005
Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals
2002
Oral Azole Drugs as Systemic Antifungal Therapy
1994
The Pharmacokinetics and Safety of Micafungin, a Novel Echinocandin, in Premature Infants
2006
Invasive Infection Due to Candida krusei in Immunocompromised Patients Not Treated with Fluconazole
1995
Problems and Controversies in the Management of Hematogenous Candidiasis
1996
Voriconazole: A New Triazole Antifungal Agent
2003 Standout
Use of Fluconazole in the Treatment of Candidal Endophthalmitis
1995
Candida Pericarditis: Clinical Profile and Treatment
1997
Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases
1998
Duration of Antifungal Treatment and Development of Delayed Complications in Patients with Candidaemia
2003
High‐dose therapy with fluconazole ≥ 800 mg day‐1
1997
Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years
2003
Candidemia as a cause of septic shock and multiple organ failure in nonimmunocompromised patients
2002
Candida tropicalis Vertebral Osteomyelitis: A Late Sequela of Fungemia
1994
ICU-acquired immunosuppression and the risk for secondary fungal infections
2010
Candida glabrata Fungemia Clinical Features of 139 Patients
1999
Fluconazole versus Amphotericin B in the treatment of Hematogenous Candidiasis: A matched cohort study
1996
Retrospective Analysis of the Dosage of Amphotericin B Lipid Complex for the Treatment of Invasive Fungal Infections
1999
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals
2007
The search for new triazole antifungal agents
1997
Amphotericin B Use in a Community Hospital, with Special Emphasis on Side Effects
1998
Predictors and Outcomes of Candiduria in Renal Transplant Recipients
2005
Immunity to fungal infections
2011 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Attributable Mortality of Nosocomial Candidemia, Revisited
2003
Prophylactic Antifungal Therapy in the Intensive Care Unit
2001
Fungal Eye Disease at a Tertiary Care Center: The Utility of Routine Inpatient Consultation
2011
Factors prompting early central venous catheter removal from cancer patients with candidaemia
2010
Predictors of Adverse Outcome in Cancer Patients with Candidemia
1998
Infection in Organ-Transplant Recipients
1998 Standout
Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
1999
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Guillain-Barré syndrome
2005 Standout
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Emergence ofCandida parapsilosisas the Predominant Species Causing Candidemia in Children
1998
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis?
2000
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
FUNGAL INFECTIONS IN SOLID ORGAN TRANSPLANT RECIPIENTS
1995
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts
1998
Residual health status after Guillain-Barre syndrome.
1997
In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens
1998
Zygomycetes in Human Disease
2000 Standout
Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain
2013
Therapeutic Approaches in Patients With Candidemia
1995
Vivid dreams, hallucinations, psychosis and REM sleep in Guillain–Barré syndrome
2005
PCR identification of four medically important Candida species by using a single primer pair
1994
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Invasive Candidiasis
2015 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Increasing Incidence of Candidemia: Results from a 20-Year Nationwide Study in Iceland
2002
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
1999
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Candida glabrata : Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
1999
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality
2005 Standout
Risk Factors for Death in Patients with Candidemia
1998
Epidemiology, Diagnosis, and Therapy of Fungal Infections in Surgery
1996
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
Risk factors for invasive fungal infections complicating orthotopic liver transplantation.
1994
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Burn Wound Infections
2006 Standout
An Extracellular Matrix–Based Mechanism of Rapid Neutrophil Extracellular Trap Formation in Response to Candida albicans
2013
Treatment of murine Candida krusei or Candida glabrata infection with L-743,872
1997
Controlled Comparison of BacT/ALERT FAN Aerobic Medium and BACTEC Fungal Blood Culture Medium for Detection of Fungemia
2001
Epidemiology of nosocomial fungal infections
1996
Guidelines for Treatment of Candidiasis
2004 Standout
Neonatal Candidemia and End-Organ Damage: A Critical Appraisal of the Literature Using Meta-analytic Techniques
2003
Detection and identification of fungal pathogens in blood by using molecular probes
1997 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Prospects for the development of fungal vaccines
1997
Therapeutic approach to Candida sepsis
1999
Works of J Dunkel being referenced
Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of Mortality
1992
Guillam- Barré Syndrome: Psychosocial Aspects Of Management
1983